Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Rouse

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Clinical Orthopaedics and Related Research|August 15, 2006
Local antibiotic delivery with OsteoSet, DBX, and CollagraftAndras Heijink, Michael J Yaszemski, Robin Patel, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 2005
Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitisMark S Rouse, Kerryl E Piper, Melissa Jacobson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2002
Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxisRaymund R Razonable, Mark R Litzow, Yasmin Khaliq, et al.
Clinical Orthopaedics and Related Research|February 14, 2006
Comparative study of antimicrobial release kinetics from polymethylmethacrylatePaloma Anguita-Alonso, Mark S Rouse, Kerryl E Piper, et al.
Journal of Clinical Microbiology|October 2, 2002
Reevaluation of Streptococcus bovis endocarditis cases from 1975 to 1985 by 16S ribosomal DNA sequence analysisInmaculada A Herrero, Mark S Rouse, Kerryl E Piper, et al.
Clinical Orthopaedics and Related Research|November 24, 2004
Gentamicin and vancomycin do not impair experimental fracture healingAbdul A Haleem, Mark S Rouse, David G Lewallen, et al.
Diagnostic Microbiology and Infectious Disease|February 6, 2004
In vitro activity of BAL9141 against clinical isolates of gram-negative bacteriaNicolas C Issa, Mark S Rouse, Kerryl E Piper, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureusMark S Rouse, Margalida Rotger, Kerryl E Piper, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2008
Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilmsJose L del Pozo, Mark S Rouse, Jayawant N Mandrekar, et al.
BMC Infectious Diseases|May 2, 2009
Daptomycin in experimental murine pneumococcal meningitisBarry B Mook-Kanamori, Mark S Rouse, Cheol-In Kang, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical Orthopaedics and Related Research|August 15, 2006
Local antibiotic delivery with OsteoSet, DBX, and CollagraftAndras Heijink, Michael J Yaszemski, Robin Patel, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 2005
Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitisMark S Rouse, Kerryl E Piper, Melissa Jacobson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2002
Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxisRaymund R Razonable, Mark R Litzow, Yasmin Khaliq, et al.
Clinical Orthopaedics and Related Research|February 14, 2006
Comparative study of antimicrobial release kinetics from polymethylmethacrylatePaloma Anguita-Alonso, Mark S Rouse, Kerryl E Piper, et al.
Journal of Clinical Microbiology|October 2, 2002
Reevaluation of Streptococcus bovis endocarditis cases from 1975 to 1985 by 16S ribosomal DNA sequence analysisInmaculada A Herrero, Mark S Rouse, Kerryl E Piper, et al.
Clinical Orthopaedics and Related Research|November 24, 2004
Gentamicin and vancomycin do not impair experimental fracture healingAbdul A Haleem, Mark S Rouse, David G Lewallen, et al.
Diagnostic Microbiology and Infectious Disease|February 6, 2004
In vitro activity of BAL9141 against clinical isolates of gram-negative bacteriaNicolas C Issa, Mark S Rouse, Kerryl E Piper, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureusMark S Rouse, Margalida Rotger, Kerryl E Piper, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2008
Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilmsJose L del Pozo, Mark S Rouse, Jayawant N Mandrekar, et al.
BMC Infectious Diseases|May 2, 2009
Daptomycin in experimental murine pneumococcal meningitisBarry B Mook-Kanamori, Mark S Rouse, Cheol-In Kang, et al.
Pageof 3